BioBridgeXAll companies

Telomir Pharmaceuticals, Inc.

Pharmaceutical company · Miami, Florida, United States · Nasdaq: TELO

Telomir Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Miami, Florida, United States. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker TELO. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Telomir Pharmaceuticals at a glance

Typepharmaceutical company
HeadquartersMiami, Florida, United States
Earliest incorporation on record2021
Stock listingNasdaq: TELO
SEC industryPharmaceutical Preparations
SEC CIK1971532

What does Telomir Pharmaceuticals do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $1 million sold (2023).

Frequently asked questions about Telomir Pharmaceuticals

Where is Telomir Pharmaceuticals headquartered?

Telomir Pharmaceuticals, Inc. is headquartered in Miami, Florida, United States.

What does Telomir Pharmaceuticals do?

Telomir Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Telomir Pharmaceuticals a public company?

Yes. Telomir Pharmaceuticals, Inc. trades on Nasdaq under the ticker TELO.

When was Telomir Pharmaceuticals founded?

The earliest incorporation on record for Telomir Pharmaceuticals, Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences